Home » FDA, ICH Outline Updated Testing Procedures for Biologics
FDA, ICH Outline Updated Testing Procedures for Biologics
December 17, 2009
The FDA is publishing an International Conference on Harmonisation (ICH) draft guideline that updates and explains specific preclinical steps drugmakers
should take to facilitate the conduct of product development and clinical trials for biotechnology-derived drugs.
To View This Article:
Subscribe To International Pharmaceutical Regulatory Monitor